Aurinia Pharmaceuticals (AUPH)

Aurinia Pharmaceuticals (AUPH) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AUPH last traded at $16.11, -3.24% on the day.
• Aurinia Pharmaceuticals: market cap $2.23B, P/E 6.8, revenue $321.74M over the last four quarters.
• Over the past year AUPH returned 32.92%; year to date 1.00%.

Updated 2026-11-02 23:10 UTC